Comparative evaluation of intranasal dexmedetomidine, intranasal midazolam, and nitrous oxide for conscious sedation of anxious children undergoing dental treatment: A randomized cross-over trial
Vergleich von intranasalem Dexmedetomidin, intranasalem Midazolam und Lachgas für die bewusste Sedierung ängstlicher Kinder bei zahnärztlicher Behandlung: randomisierte Crossover-Studie
Journal of Indian Society of Pedodontics and Preventive Dentistry · 2024-04 · 42 (2) · 141-148
DOI: 10.4103/jisppd.jisppd_104_24 ↗Auf einen Blick
Bei 15 Kindern im Alter von 6–8 Jahren waren Dexmedetomidin, Midazolam und Lachgas gleich wirksam für das Gesamtverhalten. Dexmedetomidin hatte jedoch einen längeren Sedierungsbeginn.
Fragestellung
Vergleich von 1 m/kg intranasalem Dexmedetomidin, 0,3 mg/kg intranasalem Midazolam und Lachgas hinsichtlich Sedierung, Verhalten, Beginn der Sedierung, physiologischer Zeichen und Nebenwirkungen.
Methode
Randomisierte Crossover-Studie mit 15 Kindern; drei Behandlungsbesuche im Abstand von 1 Woche. Bei jedem Termin wurde nach Gabe des Sedativums eine einzelne Pulpektomie durchgeführt.
Ergebnisse
Alle drei Sedativa kontrollierten das Gesamtverhalten gleich gut. Dexmedetomidin hatte niedrigere Sedierungsscores und den längsten Sedierungsbeginn mit 36,2 ± 9,47 min. Husten und Niesen traten vor allem nach Midazolam auf.
Schlussfolgerung der Autor:innen
0,3 mg/kg intranasales Midazolam war so wirksam wie Lachgas zur Verhaltenskontrolle und für eine ausreichende Sedierung. Dexmedetomidin erreichte nicht das gleiche Sedierungsniveau und wirkte langsamer.
Kernaussagen
- Gleiches Gesamtverhalten unter allen 3 Sedativa
- Dexmedetomidin: längster Sedierungsbeginn (36,2 ± 9,47 min)
- Midazolam: Husten und Niesen häufiger; O2-Sättigung niedriger
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Indian Society of Pedodontics and Preventive Dentistry, online erschienen am 28.06.2024. Verfasst von Palak Janiani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Preventive Dentistry, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, Ind…. Hauptthemen laut MEDLINE: Nitrous Oxide, Midazolam, Administration, Intranasal, Cross-Over Studies. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Pharmacological methods, specifically sedatives, have gained popularity in managing the behavior of children during dental appointments.
Aim
The aim of this study was to compare 1 m/kg intranasal dexmedetomidine, 0.3 mg/kg intranasal midazolam, and nitrous oxide in evaluating the level of sedation, behavior of the child, onset of sedation, physiologic signs, and adverse effects. Materials and Methods In this cross-over trial, 15 children aged 6–8 years were randomized to receive intranasal atomized dexmedetomidine, intranasal atomized midazolam, and inhalation nitrous oxide at three separate visits. After administering the sedative agent, a single pulpectomy was performed during each appointment, and the outcomes were recorded. The washout period between each visit was 1 week.
Results
All three sedative agents were equally effective in controlling overall behavior. Dexmedetomidine showed lower sedation level scores (agitated; score 9) than the other groups. There was a statistically significant difference in the onset of sedation, with dexmedetomidine having the longest onset of 36.2 ± 9.47 min. Coughing and sneezing were predominantly observed after administration of intranasal midazolam. Oxygen saturation levels were statistically lower in the intranasal midazolam group during local anesthesia administration and post-treatment.
Conclusion
0.3 mg/kg intranasal midazolam is as effective as nitrous oxide sedation for controlling behavior and providing adequate sedation in pediatric dental patients. However, 1 m/kg dexmedetomidine did not provide the same level of sedation and had a significantly longer onset. 0.3 mg/kg intranasal midazolam is an effective alternative to nitrous oxide sedation in anxious children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric and Preventive Dentistry, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
- Department of Anaesthesiology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
Zitieren
APA
Janiani, P., Gurunathan, D., & Manohar, R. (2024). Comparative evaluation of intranasal dexmedetomidine, intranasal midazolam, and nitrous oxide for conscious sedation of anxious children undergoing dental treatment: A randomized cross-over trial. Journal of Indian Society of Pedodontics and Preventive Dentistry, 42(2), 141-148. https://doi.org/10.4103/jisppd.jisppd_104_24
Vancouver
Janiani P, Gurunathan D, Manohar R. Comparative evaluation of intranasal dexmedetomidine, intranasal midazolam, and nitrous oxide for conscious sedation of anxious children undergoing dental treatment: A randomized cross-over trial. Journal of Indian Society of Pedodontics and Preventive Dentistry. 2024;42(2):141-148. doi:10.4103/jisppd.jisppd_104_24
BibTeX
@article{Janiani2024,
author = {Janiani, Palak and Gurunathan, Deepa and Manohar, Ramsesh},
title = {Comparative evaluation of intranasal dexmedetomidine, intranasal midazolam, and nitrous oxide for conscious sedation of anxious children undergoing dental treatment: A randomized cross-over trial},
journal = {Journal of Indian Society of Pedodontics and Preventive Dentistry},
year = {2024},
volume = {42},
number = {2},
pages = {141--148},
doi = {10.4103/jisppd.jisppd_104_24}
}
EUVIMED